231 related articles for article (PubMed ID: 31244287)
1. Over-Expression of Cyclooxygenase-2 in Colorectal Cancer Patients.
Negi RR; Rana SV; Gupta V; Gupta R; Chadha VD; Prasad KK; Dhawan DK
Asian Pac J Cancer Prev; 2019 Jun; 20(6):1675-1681. PubMed ID: 31244287
[TBL] [Abstract][Full Text] [Related]
2. Factors that contribute to faecal cyclooxygenase-2 mRNA expression in subjects with colorectal cancer.
Hamaya Y; Yoshida K; Takai T; Ikuma M; Hishida A; Kanaoka S
Br J Cancer; 2010 Mar; 102(5):916-21. PubMed ID: 20145612
[TBL] [Abstract][Full Text] [Related]
3. Effects of cyclooxygenase-2 inhibition on serum and tumor gastrins and expression of apoptosis-related proteins in colorectal cancer.
Konturek PC; Rembiasz K; Burnat G; Konturek SJ; Tusinela M; Bielanski W; Rehfeld J; Karcz D; Hahn E
Dig Dis Sci; 2006 Apr; 51(4):779-87. PubMed ID: 16615003
[TBL] [Abstract][Full Text] [Related]
4. Decreased expression of semaphorin 3D is associated with genesis and development in colorectal cancer.
Wang Z; Ding M; Qian N; Song B; Yu J; Tang J; Wang J
World J Surg Oncol; 2017 Mar; 15(1):67. PubMed ID: 28320475
[TBL] [Abstract][Full Text] [Related]
5. Correlations of IGF-1R and COX-2 Expressions with Ras and BRAF Genetic Mutations, Clinicopathological Features and Prognosis of Colorectal Cancer Patients.
Jin M; Long ZW; Yang J; Lin X
Pathol Oncol Res; 2018 Jan; 24(1):45-57. PubMed ID: 28188432
[TBL] [Abstract][Full Text] [Related]
6. Correlation of COX-2 and MMP-13 expressions with gastric cancer and their effects on prognosis.
Ren J; Liu J; Sui X
J BUON; 2019; 24(1):187-193. PubMed ID: 30941969
[TBL] [Abstract][Full Text] [Related]
7. Over-expression of COX-2 mRNA in colorectal cancer.
Roelofs HM; Te Morsche RH; van Heumen BW; Nagengast FM; Peters WH
BMC Gastroenterol; 2014 Jan; 14():1. PubMed ID: 24383454
[TBL] [Abstract][Full Text] [Related]
8. Impact of cyclooxygenase-2 over-expression on the prognosis of colorectal cancer patients. An experience from Western Saudi Arabia.
Albasri AM; Elkablawy MA; Hussainy AS; Yousif HM; Alhujaily AS
Saudi Med J; 2018 Aug; 39(8):773-780. PubMed ID: 30106414
[TBL] [Abstract][Full Text] [Related]
9.
Fredericks E; Dealtry G; Roux S
Can J Gastroenterol Hepatol; 2018; 2018():4379673. PubMed ID: 30186819
[TBL] [Abstract][Full Text] [Related]
10. Expression and association of carbonic anhydrase IX and cyclooxygenase-2 in colorectal cancer.
Tupá V; Drahošová S; Grendár M; Adamkov M
Pathol Res Pract; 2019 Apr; 215(4):705-711. PubMed ID: 30638861
[TBL] [Abstract][Full Text] [Related]
11. Correlated non-nuclear COX2 and low HER2 expression confers a good prognosis in colorectal cancer.
Zhou FF; Huang R; Jiang J; Zeng XH; Zou SQ
Saudi J Gastroenterol; 2018; 24(5):301-306. PubMed ID: 29873317
[TBL] [Abstract][Full Text] [Related]
12. Differential expression of IGF-1 mRNA isoforms in colorectal carcinoma and normal colon tissue.
Kasprzak A; Szaflarski W; Szmeja J; Andrzejewska M; Przybyszewska W; Kaczmarek E; Koczorowska M; Kościński T; Zabel M; Drews M
Int J Oncol; 2013 Jan; 42(1):305-16. PubMed ID: 23165777
[TBL] [Abstract][Full Text] [Related]
13. Interplay between post-translational cyclooxygenase-2 modifications and the metabolic and proteomic profile in a colorectal cancer cohort.
Prieto P; Jaén RI; Calle D; Gómez-Serrano M; Núñez E; Fernández-Velasco M; Martín-Sanz P; Alonso S; Vázquez J; Cerdán S; Peinado MÁ; Boscá L
World J Gastroenterol; 2019 Jan; 25(4):433-446. PubMed ID: 30700940
[TBL] [Abstract][Full Text] [Related]
14. Rat colorectal tumours treated with a range of non-steroidal anti-inflammatory drugs show altered cyclooxygenase-2 and cyclooxygenase-1 splice variant mRNA expression levels.
Vogiagis D; Brown W; Glare EM; O'Brien PE
Carcinogenesis; 2001 Jun; 22(6):869-74. PubMed ID: 11375891
[TBL] [Abstract][Full Text] [Related]
15. Involvement of adiponectin in early stage of colorectal carcinogenesis.
Tae CH; Kim SE; Jung SA; Joo YH; Shim KN; Jung HK; Kim TH; Cho MS; Kim KH; Kim JS
BMC Cancer; 2014 Nov; 14():811. PubMed ID: 25370174
[TBL] [Abstract][Full Text] [Related]
16. miR-1260b is a Potential Prognostic Biomarker in Colorectal Cancer.
Liu DR; Guan QL; Gao MT; Jiang L; Kang HX
Med Sci Monit; 2016 Jul; 22():2417-23. PubMed ID: 27399918
[TBL] [Abstract][Full Text] [Related]
17. Stromal cell derived factor-1 and CXCR4 expression in colorectal cancer promote liver metastasis.
Amara S; Chaar I; Khiari M; Ounissi D; Weslati M; Boughriba R; Hmida AB; Bouraoui S
Cancer Biomark; 2015; 15(6):869-79. PubMed ID: 26406413
[TBL] [Abstract][Full Text] [Related]
18. LGR5 and CD133 as prognostic and predictive markers for fluoropyrimidine-based adjuvant chemotherapy in colorectal cancer.
Stanisavljević L; Myklebust MP; Leh S; Dahl O
Acta Oncol; 2016 Dec; 55(12):1425-1433. PubMed ID: 27435662
[TBL] [Abstract][Full Text] [Related]
19. Expression analysis and clinical significance of eIF4E, VEGF-C, E-cadherin and MMP-2 in colorectal adenocarcinoma.
Gao M; Zhang X; Li D; He P; Tian W; Zeng B
Oncotarget; 2016 Dec; 7(51):85502-85514. PubMed ID: 27907907
[TBL] [Abstract][Full Text] [Related]
20. CYP24A1 is a potential biomarker for the progression and prognosis of human colorectal cancer.
Sun H; Wang C; Hao M; Sun R; Wang Y; Liu T; Cong X; Liu Y
Hum Pathol; 2016 Apr; 50():101-8. PubMed ID: 26997443
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
